Aigen Investment Management, LP Agenus Inc Transaction History

Aigen Investment Management, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$1.12 - $1.88 $33,798 - $56,732	-30,177 Reduced 54.39%	25,307 $28,000
Q2 2023 Aug 14, 2023	SELL	$1.31 - $2.04 $42,438 - $66,087	-32,396 Reduced 36.86%	55,484 $88,000
Q1 2023 May 15, 2023	BUY	$1.45 - $2.95 $127,426 - $259,246	87,880 New	87,880 $133,000
Q4 2021 Feb 11, 2022	SELL	$2.92 - $5.74 $49,187 - $96,690	-16,845 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$4.98 - $6.63 $83,888 - $111,682	16,845 New	16,845 $88,000
Q1 2021 May 11, 2021	SELL	$2.69 - $5.25 $68,985 - $134,636	-25,645 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$3.17 - $4.49 $81,294 - $115,146	25,645 New	25,645 $82,000
Q3 2020 Nov 06, 2020	SELL	$2.98 - $5.2 $137,085 - $239,210	-46,002 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$2.29 - $4.24 $105,344 - $195,048	46,002 New	46,002 $181,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.